Craft

Anterogen

Stock Price

₩15 K

2024-10-29

Market Capitalization

₩146 B

2024-10-29

Revenue

₩7.5 B

FY, 2025

Anterogen Summary

Company Summary

Overview
Anterogen is a biotech company that researches and develops cell therapy products and drugs using adult stem cells. Its products include Cupistem, Adipocell, Queencell, etc.
Type
Public
Status
Active
Founded
2000
HQ
KR | view all locations
Website
http://www.anterogen.com
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Seoul HQ

    Korea (Republic of)

    345-30 Gasan-dong, Geumcheon-gu

Anterogen Financials

Summary Financials

Revenue (FY, 2025)
₩7.5B
Gross profit (FY, 2025)
₩3.0B
Net income (FY, 2025)
(₩1.4B)
Cash (FY, 2025)
₩1.6B
EBIT (FY, 2025)
(₩2.4B)

Footer menu